O-29 - Innovations in Diagnostics

Co-Author(s)

• AA

  Archana Asundi, MD

  Assistant Professor
  Boston Medical Center
  Boston, Massachusetts

  Disclosure: Gilead (Scientific Research Study Investigator)Merck (Scientific Research Study Investigator)ViiV (Scientific Research Study Investigator)
• TB

  Taylor Banks, MD

  Allergist/Immunologist
  Medicine
  Naval Medical Center Portsmouth
  Bethesda, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• NB

  Nicole Billings, PhD

  Director, Lab Services
  Day Zero Diagnostics
  Boston, Massachusetts

  Disclosure: Day Zero Diagnostics: Employee
• JB

  Jennifer Bombard, n/a

  Senior Research Assistant
  Infectious Diseases
  Boston Medical Center
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MC

  Michelle Chen, MS

  Research Associate
  Day Zero Diagnostics
  Boston, Massachusetts

  Disclosure: Day Zero Diagnostics (Employee, Shareholder)
• LC

  Lisa Cunden, PhD

  Research Scientist
  Day Zero Diagnostics
  Cambridge, Massachusetts

  Disclosure: Day Zero Diagnostics (Shareholder)
• SD

  Samuel Dominguez, MD, PhD

  Associate Professor
  Pediatric Infecitous Disease
  University of Colorado, School of Medicine
  San Francisco, California

  Disclosure: BioFire (Consultant, Research Grant or Support)
• IH

  Ian Herriott, BS

  Manager of Sequencing Technologies
  Day Zero Diagnostics
  Boston, Massachusetts

  Disclosure: Day Zero Diagnostics (Employee, Shareholder)
• MH

  Miriam Huntley, PhD

  Chief Technology Officer
  Day Zero Diagnostics
  Boston, Massachusetts

  Disclosure: Day Zero Diagnostics (Employee, Shareholder)
• PK

  Paul Knysh, PhD

  Research Scientist, Machine Learning
  Day Zero Diagnostics
  Boston, Massachusetts

  Disclosure: Day Zero Diagnostics (Employee)
• MK

  Michael Kumcu, MS

  Research Associate II
  Day Zero Diagnostics
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• ML

  Molly Lamb, PhD

  Assistant Professor
  Colorado School of Public Health
  Aurora, Colorado

  Disclosure: BioFire (Grant/Research Support)
• CM

  Cabell Maddux, n/a

  Senior Software Engineer
  Day Zero Diagnostics
  Providence, Rhode Island

  Disclosure: Day Zero Diagnostics (Employee, Shareholder)
• RM

  Rachel Martin, n/a

  Research Associate
  Day Zero Diagnostics
  Watertown, Massachusetts

  Disclosure: Day Zero DIagnostics (Employee)
• RM

  Rakesh Mistry, MD, MSCE

  Associate Professor
  Pediatrics
  University of Colorado School of Medicine
  Aurora, Colorado

  Disclosure: BioFire (Grant/Research Support)
• AM

  Angela Moss, MS

  Data analyst
  University of Colorado School of Medicine
  Aurora, Colorado

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• ZM

  Zachary Munro, n/a

  Software Engineer
  Day Zero Diagnostics Inc.
  Somerville, Massachusetts

  Disclosure: Day Zero Diagnostics Inc. (Employee, Shareholder)
• IN

  Imaly Nanayakkara, PhD

  Research Scientist
  Day Zero Diagnostics
  Boston, Massachusetts

  Disclosure: Day Zero Diagnostics (Employee, Shareholder)
• FP

  Febriana Pangestu, n/a

  Genomics Sequencing Technician
  Day Zero Diagnostics
  Boston, Massachusetts

  Disclosure: Day Zero Diagnostics (Employee, Shareholder)
• BR

  Brian Reinhardt, n/a

  Lab Technician
  Biomedical Research Laboratory
  Walter Reed National Military Medical Center
  Bethesda, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SR

  Samantha Roche, BA, MPH

  Study Coordinator
  Boston Medical Center
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• ZR

  Zoe Rogers, MPH

  Clinical Affairs Manager
  Day Zero Diagnostics
  Allston, Massachusetts

  Disclosure: Day Zero Diagnostics (Employee, Shareholder)
• RT

  Robert Taylor, Ph.D

  Scientist
  Biomedical Research Laboratory
  Walter Reed National Military Medical Center
  Bethesda, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Chiahao Tsui

  Senior Research Scientist
  Day Zero Diagnostics
  Somerville, MA

  Disclosure: Day Zero Diagnostics (Employee, Shareholder)
• NW

  Nora Watson, Ph.D

  Statistician
  Research Programs
  Walter Reed National Military Medical Center
  Bethesda, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presenting Author(s)

• 

  Janine Danko, MD MPH FACP CPE

  Deputy Director, Medical Services
  Walter Reed National Military Medical Center
  West Friendship, MD

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• NL

  Nina Lin, MD

  Assistant Professor
  Boston University
  Boston, MA

  Disclosure: Gilead Sciences: Scientific Research Study Investigator; ViiV: Scientific Research Study Investigator

  Slides Slides and Audio
• 

  Suchitra Rao, MBBS, MSCS

  Associate Professor
  University of Colorado School of Medicine
  Denver, CO

  Disclosure: BioFire (Grant/Research Support)

  Slides Slides and Audio
• 

  Chiahao Tsui

  Senior Research Scientist
  Day Zero Diagnostics
  Somerville, MA

  Disclosure: Day Zero Diagnostics (Employee, Shareholder)

  Slides Slides and Audio

Presentations:

• the RAPID trial: randomized Controlled Trial assessing point-of-care influenza and Other Respiratory Virus diagnostics in the Pediatric ED Setting
  Suchitra Rao, MBBS, MSCS – University of Colorado School of Medicine; Molly Lamb, PhD – Colorado School of Public Health; Angela Moss, MS – University of Colorado School of Medicine; Rakesh Mistry, MD, MSCE – University of Colorado School of Medicine; Samuel Dominguez, MD, PhD – University of Colorado, School of Medicine
• The Use of Dried Blood Spot Cards to Assess Serologic Responses of Individuals Vaccinated Against Measles, Hepatitis A, Tetanus, Influenza and Varicella Zoster
  Janine R. Danko, MD MPH FACP CPE – Walter Reed National Military Medical Center; Robert Taylor, Ph.D – Walter Reed National Military Medical Center; Brian Reinhardt, n/a – Walter Reed National Military Medical Center; Nora L. Watson, Ph.D – Walter Reed National Military Medical Center; Taylor Banks, MD – Naval Medical Center Portsmouth
• blood2bac: Species ID and AMR Prediction of Bacterial Pathogens at Low Concentrations in Blood Using a Rapid Ultra-high Enrichment Process and Nanopore Sequencing
  Chiahao Tsui – Day Zero Diagnostics; Lisa S. Cunden, PhD – Day Zero Diagnostics; Nicole Billings, PhD – Day Zero Diagnostics; Imaly A. Nanayakkara, PhD – Day Zero Diagnostics; Ian Herriott, BS – Day Zero Diagnostics; Michael E. Kumcu, MS – Day Zero Diagnostics; Rachel R. Martin, n/a – Day Zero Diagnostics; Michelle Chen, MS – Day Zero Diagnostics; Febriana Pangestu, n/a – Day Zero Diagnostics; Paul Knysh, PhD – Day Zero Diagnostics; Cabell Maddux, n/a – Day Zero Diagnostics; Zachary Munro, n/a – Day Zero Diagnostics Inc.; Miriam Huntley, PhD – Day Zero Diagnostics
• pilot Study of a Novel Whole-genome Sequencing Based Rapid Bacterial Identification Assay in Patients with Bacteremia
  Archana Asundi, MD – Boston Medical Center; Nicole Billings, PhD – Day Zero Diagnostics; Zoe H. Rogers, MPH – Day Zero Diagnostics; Samantha Roche, BA, MPH – Boston Medical Center; Jennifer Bombard, n/a – Boston Medical Center; Michael E. Kumcu, MS – Day Zero Diagnostics; Lisa S. Cunden, PhD – Day Zero Diagnostics; Imaly A. Nanayakkara, PhD – Day Zero Diagnostics; Chiahao Tsui – Day Zero Diagnostics; Paul Knysh, PhD – Day Zero Diagnostics; Cabell Maddux, n/a – Day Zero Diagnostics; Zachary Munro, n/a – Day Zero Diagnostics Inc.; Ian Herriott, BS – Day Zero Diagnostics; Miriam Huntley, PhD – Day Zero Diagnostics; Nina H. Lin, MD – Boston University